Delivery Order SPE2DB20D2104-SPE2DB22FS35Y
Award Date 4/8/22
Potential Completion Date 4/11/22
Potential Value $1.7K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Vimpat 100 mg tablets. The $4,296.19 firm fixed-price delivery order has a period of performance through December 6, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Vimpat 100 mg tablets. The $1,490.52 firm-fixed-price Delivery Order has a completion date of January 3, 2023 and is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for supplying a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Vimpat 100 mg tablets. The $1,415.46 firm fixed-price contract has an ultimate completion date of August 22, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc. The $1,103.80 firm fixed-price delivery order is for the supply of 4557217534 - Vimpat 150 mg tablets. This order does not have a set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor that provides a wide range of medical products to federal agencies, with a significant focus on serving...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,232.00 firm fixed-price delivery order is for the supply of Vimpat 10 mg/ml solution in 200 ml containers. The contract has an ultimate completion date of September 25, 2023 and was awarded on September 22, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,840.98, is for the supply of Vimpat 100 mg tablets to support military healthcare programs. It is a firm fixed-price contract with a period of performance through February 2024. The contract was not designated with a set-aside requirement, indicating open competition. AmerisourceBergen Drug Corp...
- This federal contract award, with an ID of SPE2DB20D3103|SPE2DB22FP5V0, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $5,772.92 firm-fixed-price delivery order is for the supply of Vimpat 100 mg tablets. The contract has an ultimate completion date of August 23, 2022 and was awarded on August 22, 2022. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,051.21 firm-fixed-price delivery order is for the supply of Vimpat 10 mg/ml solution, a specialty pharmaceutical product. The award has an ultimate completion date of October 23, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office division. The $1,250.80 firm-fixed price delivery order is for the supply of 60 tablets of Vimpat 200 mg, a pharmaceutical product. The contract has no set-aside designation and is scheduled for completion on July 17, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous Indefinite Delivery Contracts (IDCs) by the...
- This federal contract award, valued at $5,622.75, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of Vimpat 100 mg tablets, a prescription medication, to support military treatment programs and facilities. The contract is a firm fixed price delivery order with an ultimate completion date of April 12, 2024. No set-aside designation was used. Amerisourcebergen...